Aspire Biopharma Announces BUZZ BOMB Pre-Workout Supplement with Novel Sublingual Delivery Technology.

Aspire Biopharma has announced the brand name BUZZ BOMB for its novel sublingual pre-workout supplement, featuring 50mg of caffeine to support sustained energy and mental focus. The supplement will come in six flavors and is expected to launch in August. The company has commenced initial production and will begin expanded pre-launch consumer testing in Q2 2025.

Aspire Biopharma Holdings, Inc. (ASBP) has announced the brand name BUZZ BOMB™ for its novel sublingual pre-workout supplement, featuring 50mg of caffeine to support sustained energy and mental focus. The supplement is expected to launch in August and will come in six flavors: Tropical Fruit, Mixed Berry, Watermelon, Lemon Lime, Peach Mango, and Mocha Coffee. Aspire has commenced initial production and will begin expanded pre-launch consumer testing in Q2 2025.

BUZZ BOMB™ is designed to deliver caffeine directly to the bloodstream through sublingual nano-technology, providing nearly instant energy. This differentiates it from traditional powdered pre-workout supplements that can take 20-30 minutes to take effect. The product is packaged in convenient, on-the-go packets, making it easy to use right before and during workouts.

Aspire plans to showcase BUZZ BOMB™ at two major U.S. fitness expos in August: FITCON Expo in Salt Lake City, UT, and The Fit Expo in Anaheim, CA. The company expects to have ample product available for consumer testing and launch.

Aspire's Chief Executive Officer, Kraig Higginson, commented on the product, stating, "The introduction of Aspire's caffeine-based 'Buzz Bomb™' Sublingual Pre-Workout energy supplement has the ideal unique characteristics to disrupt the fast-growing, multi-billion-dollar Sports Nutrition and Fitness market. We are excited about the early feedback from fitness trainers and athletes who love how clean and simple our product is."

The global pre-workout supplements market is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030 [1].

References:
[1] https://www.biospace.com/press-releases/aspire-biopharma-holdings-inc-provides-development-update-on-buzz-bombtm-its-new-sublingual-pre-workout-supplement-expected-to-launch-in-third-quarter-of-2025
[2] https://www.nasdaq.com/articles/aspire-biopharma-launch-buzz-bomb-sublingual-pre-workout-begins-production-and-testing